Location History:
- Parets del Valles, ES (2012)
- Mataró, ES (2012)
- Mataro, ES (2012)
- Barcelona, ES (2019)
Company Filing History:
Years Active: 2012-2019
Title: Montserrat Costa Rierola: Innovator in Human Albumin Preparation
Introduction
Montserrat Costa Rierola is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of biomedicine, particularly in the preparation of human albumin and mammalian cell culture media. With a total of 4 patents to her name, her work has the potential to impact various medical applications.
Latest Patents
One of her latest patents is a method for the preparation of human albumin with a reduced level of dissolved oxygen. This innovative method prepares a solution of human albumin by reducing dissolved oxygen in the solution until a concentration of oxygen equal to or less than 0.5 ppm is achieved. This process results in a solution of human albumin that has a redox state closer to that of albumin present in human plasma. Another notable patent involves mammalian cell culture media that comprise supernatant from Cohn fractionation stages. This invention relates to the use of supernatant from specific fractions of human plasma fractionation, which provides essential nutrients and factors for the effective maintenance and proliferation of cultured mammalian cells.
Career Highlights
Montserrat has worked with notable companies such as Grifols, S.A. and Grifols Worldwide Operations Limited. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in the field.
Collaborations
Throughout her career, Montserrat has collaborated with esteemed colleagues, including Juan Ignacio Jorquera Nieto and Pere Ristol Debart. These collaborations have further enriched her research and development efforts.
Conclusion
Montserrat Costa Rierola is a distinguished inventor whose work in human albumin preparation and mammalian cell culture media showcases her innovative spirit. Her contributions are poised to make a lasting impact in the biomedical field.